Genetic and other diagnostic US test regs need overhaul for personalized medicine

10 May 2009

To "get personalized medicine right," US Health and Human Services Secretary Kathleen Sebelius will need to "create and implement a  reasonable and responsible regulatory framework" for genetic tests and  other advanced medical diagnostics, according to a diverse group of  more than a hundred organizations representing genetic testing  laboratories, patient advocates, investors and health policy  researchers, going under the banner The Coalition for 21st Century  Medicine,.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight